<SEC-DOCUMENT>0001628280-18-000664-index.html : 20180129
<SEC-HEADER>0001628280-18-000664.hdr.sgml : 20180129
<ACCEPTANCE-DATETIME>20180129160236
ACCESSION NUMBER:		0001628280-18-000664
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20180129
DATE AS OF CHANGE:		20180129
EFFECTIVENESS DATE:		20180129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Menlo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001566044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				453757789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-222758
		FILM NUMBER:		18555534

	BUSINESS ADDRESS:	
		STREET 1:		4085 CAMPBELL AVENUE, SUITE 200
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-486-1416

	MAIL ADDRESS:	
		STREET 1:		4085 CAMPBELL AVENUE, SUITE 200
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tigercat Pharma, Inc.
		DATE OF NAME CHANGE:	20130104
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>menlos-8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: menlos-8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit51.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
Document 2 - file: exhibit51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>exhibit231.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 3 - file: exhibit231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>morrisonfoerstera02.jpg
<TEXT>
Document 4 - file: morrisonfoerstera02.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>morrisonfoerstera03.jpg
<TEXT>
Document 5 - file: morrisonfoerstera03.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>sanfranciscomnlo51opi_image2.gif
<TEXT>
Document 6 - file: sanfranciscomnlo51opi_image2.gif

</DOCUMENT>
</SEC-DOCUMENT>